Variables | PCI group (n = 220) | Thrombolysis group (n = 48) | P values |
---|---|---|---|
Ages (mean ± SD, yrs) | 70.9 ± 4.32 | 69.7 ± 4.01 | 0.782 |
Males, n (%) | 144 (65.5%) | 33 (68.8%) | 0.641 |
Cardiovascular risk factors, n (%) | |||
Hypertension | 131 (59.5%) | 29 (60.4%) | 0.279 |
Diabetes | 52 (23.6%) | 11 (22.9%) | 0.321 |
Hyperlipidemia | 51 (23.2%) | 8 (16.7%) | 0.417 |
Smoking | 86 (39.1%) | 15 (31.2%) | 0.312 |
Medical histories, n (%) | |||
MI | 22 (10%) | 6 (14%) | 0.087 |
Chronic heart failure (CHF) | 13 (5.9%) | 3 (26%) | 0.098 |
Stroke | 31 (12.7%) | 10 (20.8%) | 0.059 |
Clinic events, n (%) | |||
Intracranial hemorrhage | 6 (2.7%) | 4 (8.3%) | 0.000 |
Nonfatal MI | 19 (8.6%) | 5 (10.4%) | 0.292 |
Revascularization | 25 (11.4%) | 6 (12.5%) | 0.239 |
LVEF < 45% | 29 (13.2%) | 14 (29.2%) | 0.019 |
Mortality within 1 year | 6 (2.7%) | 3 (6.3%) | 0.045 |